{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:40Z","timestamp":1772166040223,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Privately-owned cannabis clinics have sprung up in many jurisdictions where medicinal cannabis has been legalised and provide an alternative pathway for patients who are unable or unwilling to access a prescription for cannabis-based medicinal products from their usual healthcare providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to explore physicians\u2019 views on cannabis clinics, including their perceptions of the role cannabis clinics play in the wider health system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A qualitative study using in-depth, semi-structured interviews with thirty-one physicians affiliated with private and community clinics in New Zealand (including cannabis clinicians, GPs, and specialist doctors). The interviews were conducted from July to December 2021. Data were transcribed and analysed using inductive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cannabis clinicians positioned themselves as (1) \u201cservice providers\u201d, facilitating consumer access to cannabis prescriptions and products, and (2) \u201ceducators\u201d, providing advice to patients and the wider physician community. While general practitioners and specialists recognised the benefits of specialised cannabis clinics (i.e., knowledge of products and a non-judgmental environment), they questioned the limited evidence of clinical efficacy for cannabis, potential financial conflicts of interests of cannabis clinicians that may blur their clinical judgement, and the risk of compartmentalising patients\u2019 healthcare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our paper raises a number of challenges with attempting to integrate cannabis clinics into the wider health system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-022-09021-y","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T06:33:41Z","timestamp":1672814021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of cannabis clinics in the health system: a qualitative study of physicians\u2019 views in New Zealand"],"prefix":"10.1186","volume":"23","author":[{"given":"Vinuli","family":"Withanarachchie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rychert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"9021_CR1","unstructured":"Aguilar B S, Guti\u00e9rrez V, S\u00e1nchez L, Nougier M. Medicinal cannabis policies and practices around the world: International Drug Policy Consortium, 2018, April. (Briefing paper). http:\/\/fileserver.idpc.net\/library\/Medicinal%20cannabis%20briefing_ENG_FINAL.PDF."},{"key":"9021_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12954-015-0082-x","volume":"12","author":"SR Sznitman","year":"2015","unstructured":"Sznitman SR, Bretteville-Jensen AL. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies. Harm Reduct J. 2015;12:46. https:\/\/doi.org\/10.1186\/s12954-015-0082-x.","journal-title":"Harm Reduct J"},{"key":"9021_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000505028","volume":"3","author":"A Schlag","year":"2020","unstructured":"Schlag A. An evaluation of regulatory regimes of medical Cannabis: what lessons can be learned for the UK? Med Cannabis Cannabinoids. 2020;3:1\u20138. https:\/\/doi.org\/10.1159\/000505028.","journal-title":"Med Cannabis Cannabinoids"},{"key":"9021_CR4","unstructured":"Department of Cannabis Control. California\u2019s cannabis laws. 2021. Retrieved December 9, 2021 from https:\/\/cannabis.ca.gov\/resources\/laws-and-regulations\/."},{"key":"9021_CR5","unstructured":"National Health System. Cannabis-based products for medicinal use: Frequently asked questions. no date. Retrieved February 6, 2021 from https:\/\/www.england.nhs.uk\/medicines-2\/support-for-prescribers\/cannabis-based-products-for-medicinal-use\/cannabis-based-products-for-medicinal-use-frequently-asked-questions\/#who-can-prescribe-a-cannabis-based-product-for-medicinal-use."},{"key":"9021_CR6","unstructured":"Ministry of Health. Applications received for assessment against the minimum product quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019. 2022 (April 1). Retrieved April 6, 2022 from https:\/\/www.health.govt.nz\/our-work\/regulation-health-and-disability-system\/medicinal-cannabis-agency\/medicinal-cannabis-agency-information-health-professionals\/applications-received-assessment-against-minimum-product-quality-standard-under-misuse-drugs."},{"key":"9021_CR7","first-page":"7","volume":"135","author":"V Withanarachchie","year":"2022","unstructured":"Withanarachchie V, Rychert M, Wilkins C. Assessing progress with the implementation of the New Zealand medicinal Cannabis scheme. N Z Med J. 2022;135:7\u201312.","journal-title":"N Z Med J"},{"key":"9021_CR8","doi-asserted-by":"publisher","unstructured":"Manoharan R, Kemper J, Young J. Exploring the medical cannabis prescribing behaviours of New Zealand physicians. Drug Alcohol Rev. 2022;41(6):1355\u201366. https:\/\/doi.org\/10.1111\/dar.13476.","DOI":"10.1111\/dar.13476"},{"key":"9021_CR9","first-page":"54","volume":"133","author":"M Rychert","year":"2020","unstructured":"Rychert M, Wilkins C, Parker K, Graydon-Guy T. Exploring medicinal use of cannabis in a time of policy change in New Zealand. N Z Med J. 2020;133:54\u20139.","journal-title":"N Z Med J"},{"key":"9021_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.drugpo.2018.03.025","volume":"57","author":"Y Zolotov","year":"2018","unstructured":"Zolotov Y, Vulfsons S, Zarhin D, Sznitman S. Medical cannabis: an oxymoron? Physicians\u2019 perceptions of medical cannabis. Int J Drug Policy. 2018;57:4\u201310.","journal-title":"Int J Drug Policy"},{"key":"9021_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12875-019-0906-y","volume":"20","author":"LM Philpot","year":"2019","unstructured":"Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam Pract. 2019;20:17. https:\/\/doi.org\/10.1186\/s12875-019-0906-y.","journal-title":"BMC Fam Pract"},{"key":"9021_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1049909115604669","volume":"34","author":"BH Carlini","year":"2017","unstructured":"Carlini BH, Garrett SB, Carter GT. Medicinal Cannabis: a survey among health care providers in Washington state. Am J Hosp Palliat Care. 2017;34:85\u201391. https:\/\/doi.org\/10.1177\/1049909115604669.","journal-title":"Am J Hosp Palliat Care"},{"key":"9021_CR13","doi-asserted-by":"publisher","first-page":"e038687","DOI":"10.1136\/bmjopen-2020-038687","volume":"10","author":"D Nutt","year":"2020","unstructured":"Nutt D, Bazire S, Phillips LD, Schlag AK. So near yet so far: why won't the UK prescribe medical cannabis? BMJ Open. 2020;10:e038687. https:\/\/doi.org\/10.1136\/bmjopen-2020-038687.","journal-title":"BMJ Open"},{"key":"9021_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/bcp.14242","volume":"86","author":"JH Martin","year":"2020","unstructured":"Martin JH, Hall W, Fitzcharles MA, Borgelt L, Crippa J. Ensuring access to safe, effective, and affordable cannabis-based medicines. Br J Clin Pharmacol. 2020;86:630\u20134. https:\/\/doi.org\/10.1111\/bcp.14242.","journal-title":"Br J Clin Pharmacol"},{"key":"9021_CR15","doi-asserted-by":"publisher","first-page":"102740","DOI":"10.1016\/j.ctim.2021.102740","volume":"60","author":"E Prosk","year":"2021","unstructured":"Prosk E, Arboleda MF, Rapin L, El Hage C, Dworkind M. The model of care at a leading medical cannabis clinic in Canada. Complement Ther Med. 2021;60:102740. https:\/\/doi.org\/10.1016\/j.ctim.2021.102740.","journal-title":"Complement Ther Med"},{"key":"9021_CR16","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1503\/cmaj.109-5121","volume":"187","author":"S Lough","year":"2015","unstructured":"Lough S. The cannabis doctor is in. CMAJ. 2015;187:e379\u2013e80. https:\/\/doi.org\/10.1503\/cmaj.109-5121.","journal-title":"CMAJ"},{"issue":"1","key":"9021_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42238-020-00038-w","volume":"2","author":"VK Mahabir","year":"2020","unstructured":"Mahabir VK, Merchant JJ, Smith C, Garibaldi A. Medical cannabis use in the United States: a retrospective database study. J Cannabis Res. 2020;2(1):1\u20133.","journal-title":"J Cannabis Res"},{"key":"9021_CR18","volume-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","author":"National Academies of Sciences E, and Medicine","year":"2017","unstructured":"National Academies of Sciences E, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017."},{"key":"9021_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/can.2019.0025","volume":"6","author":"KM Takakuwa","year":"2021","unstructured":"Takakuwa KM, Mistretta A, Pazdernik VK, Sulak D. Education, knowledge, and practice characteristics of Cannabis physicians: a survey of the Society of Cannabis Clinicians. Cannabis Cannabinoid Res. 2021;6:58\u201365. https:\/\/doi.org\/10.1089\/can.2019.0025.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1508","key":"9021_CR20","first-page":"12","volume":"133","author":"K Oldfield","year":"2020","unstructured":"Oldfield K, Braithwaite I, Beasley R, Eathorne A, Newton-Howes G, Semprini A. Medical cannabis: knowledge and expectations in a cohort of North Island New Zealand general practitioners. NZ Med J. 2020;133(1508):12\u201328.","journal-title":"NZ Med J"},{"key":"9021_CR21","doi-asserted-by":"publisher","unstructured":"Gulbransen G, Xu W, Arroll B. Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand. BJGP Open. 2020;4. https:\/\/doi.org\/10.3399\/bjgpopen20X101010.","DOI":"10.3399\/bjgpopen20X101010"},{"key":"9021_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/978-981-10-5251-4_103","volume-title":"Handbook of research methods in health and social sciences","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V, Terry G, Hayfield N. Thematic analysis. In: Liamputtong P, editor. Handbook of research methods in health and social sciences. Singapore: Springer; 2019. p. 843\u201360."},{"issue":"4","key":"9021_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G","volume":"23","author":"M Sandelowski","year":"2000","unstructured":"Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334\u201340 3.0.co;2-g.","journal-title":"Res Nurs Health"},{"issue":"1","key":"9021_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-9-52","volume":"9","author":"MA Neergaard","year":"2009","unstructured":"Neergaard MA, Olesen F, Andersen RS, Sondergaard J. Qualitative description\u2013the poor cousin of health research? BMC Med Res Methodol. 2009;9(1):1\u20135.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"9021_CR25","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/ijerph19127499","volume":"19","author":"LJ Troup","year":"2022","unstructured":"Troup LJ, Erridge S, Ciesluk B, Sodergren MH. Perceived stigma of patients undergoing treatment with cannabis-based medicinal products. Int J Environ Res Public Health. 2022;19(12):7499.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"9021_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/JNN.0000000000000283","volume":"49","author":"J Ryan","year":"2017","unstructured":"Ryan J, Sharts-Hopko N. The experiences of medical marijuana patients: a scoping review of the qualitative literature. J Neurosci Nurs. 2017;49(3):185\u201390.","journal-title":"J Neurosci Nurs"},{"issue":"133","key":"9021_CR27","first-page":"96","volume":"25","author":"K Oldfield","year":"2020","unstructured":"Oldfield K, Eathorne A, Maijers I, Beasley R, Semprini A, Braithwaite I. Knowledge and perspectives about the use of cannabis as a medicine: a mixed methods observational study in a cohort of New Zealand general practice patients. NZ Med J. 2020;25(133):96\u2013111.","journal-title":"NZ Med J."},{"issue":"1","key":"9021_CR28","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/ijn.12836","volume":"27","author":"S Melnikov","year":"2021","unstructured":"Melnikov S, Aboav A, Shalom E, Phriedman S, Khalaila K. The effect of attitudes, subjective norms and stigma on health-care providers' intention to recommend medicinal cannabis to patients. Int J Nurs Pract. 2021 Feb;27(1):e12836.","journal-title":"Int J Nurs Pract"},{"key":"9021_CR29","doi-asserted-by":"publisher","unstructured":"Grotenhermen F. The German medical cannabis law of 2017. Drugs and Alcohol Today. 2018;18(2):117\u201322. https:\/\/doi.org\/10.1108\/DAT-03-2018-0012.","DOI":"10.1108\/DAT-03-2018-0012"},{"key":"9021_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1377\/hlthaff.2015.0528","volume":"35","author":"AR Williams","year":"2016","unstructured":"Williams AR, Olfson M, Kim JH, Martins SS, Kleber HD. Older, less regulated medical marijuana programs have much greater enrollment rates than newer 'Medicalized' programs. Health Aff. 2016;35:480\u20138. https:\/\/doi.org\/10.1377\/hlthaff.2015.0528.","journal-title":"Health Aff"},{"key":"9021_CR31","doi-asserted-by":"publisher","first-page":"102675","DOI":"10.1016\/j.ctim.2021.102675","volume":"58","author":"Y Zolotov","year":"2021","unstructured":"Zolotov Y, Metri S, Calabria E, Kogan M. Medical cannabis education among healthcare trainees: a scoping review. Complement Ther Med. 2021;58:102675.","journal-title":"Complement Ther Med"},{"issue":"1","key":"9021_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-019-0906-y","volume":"20","author":"LM Philpot","year":"2019","unstructured":"Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam Pract. 2019;20(1):1\u20137.","journal-title":"BMC Fam Pract"},{"issue":"1155","key":"9021_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/postgradmedj-2020-139013","volume":"98","author":"K Oldfield","year":"2022","unstructured":"Oldfield K, Eathorne A, Tewhaiti-Smith J, Beasley R, Semprini A, Braithwaite I. Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of New Zealand doctors in an oncology setting. Postgrad Med J. 2022;98(1155):35\u201342.","journal-title":"Postgrad Med J"},{"key":"9021_CR34","doi-asserted-by":"publisher","unstructured":"Ziemianski D, Capler R, Tekanoff R, Lacasse A, Luconi F, Ware MA. Cannabis in medicine: a national educational needs assessment among Canadian physicians. BMC Med Educ. 2015;15(1):1\u20137. https:\/\/doi.org\/10.1186\/s12909-015-0335-0.","DOI":"10.1186\/s12909-015-0335-0"},{"issue":"7","key":"9021_CR35","first-page":"437","volume":"17","author":"T Ebert","year":"2015","unstructured":"Ebert T, Zolotov Y, Eliav S, Ginzburg O, Shapira I, Magnezi R. Assessment of israeli physicians\u2019 knowledge, experience and attitudes towards medical cannabis: a pilot study. Isr Med Assoc J. 2015;17(7):437\u201341 pmid:26357721.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"9021_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3122\/jabfm.2013.01.120089","volume":"26","author":"E Kondrad","year":"2013","unstructured":"Kondrad E, Reid A. Colorado family physicians' attitudes toward medical marijuana. J Am Board Fam Med. 2013;26(1):52\u201360 pmid:23288281.","journal-title":"J Am Board Fam Med"},{"key":"9021_CR37","unstructured":"Rychert M, Wilkins C, Withanarachchie V. Why it\u2019s time to treat medicinal cannabis as an alternative therapy, not a pharmaceutical. The Conversation 2021 Oct [cited 2022 Aug 17]. Available from: https:\/\/theconversation.com\/why-its-time-to-treat-medicinal-cannabis-as-an-alternative-therapy-not-a-pharmaceutical-169458"},{"key":"9021_CR38","doi-asserted-by":"publisher","first-page":"102935","DOI":"10.1016\/j.drugpo.2020.102935","volume":"85","author":"IS McGregor","year":"2020","unstructured":"McGregor IS, Cairns EA, Abelev S, Cohen R, Henderson M, Couch D, et al. Access to cannabidiol without a prescription: a cross-country comparison and analysis. Int J Drug Policy. 2020;85:102935. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102935.","journal-title":"Int J Drug Policy"},{"key":"9021_CR39","unstructured":"Therapeutic Goods Administration [Internet]. Canberra (AU): Over-the-counter access to low dose cannabidiol; 2020 [cited 2022 Dec 06]. Available from: https:\/\/www.tga.gov.au\/news\/media-releases\/over-counter-access-low-dose-cannabidiol"},{"key":"9021_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fphar.2016.00309","volume":"7","author":"EB Russo","year":"2016","unstructured":"Russo EB. Current therapeutic cannabis controversies and clinical trial design issues. Front Pharmacol. 2016;7:309.","journal-title":"Front Pharmacol"},{"issue":"1","key":"9021_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s43441-021-00346-0","volume":"56","author":"R Banerjee","year":"2022","unstructured":"Banerjee R, Erridge S, Salazar O, Mangal N, Couch D, Pacchetti B, et al. Real world evidence in medical cannabis research. Therapeut Innov Regulat Sci. 2022;56(1):8\u201314.","journal-title":"Therapeut Innov Regulat Sci"},{"issue":"5","key":"9021_CR42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00213-021-05855-2","volume":"239","author":"C Sakal","year":"2022","unstructured":"Sakal C, Lynskey M, Schlag AK, Nutt DJ. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from project Twenty21. Psychopharmacology. 2022;239(5):1147\u201355.","journal-title":"Psychopharmacology."},{"key":"9021_CR43","volume-title":"Australian medicinal Cannabis industry report","author":"MedTech and Pharma Growth Centre","year":"2021","unstructured":"MedTech and Pharma Growth Centre. Australian medicinal Cannabis industry report. Victoria (AU): Department of Industry, Science, Engery, and Resources \u2013 Australian Governemt; 2021. Available from: https:\/\/www.mtpconnect.org.au\/images\/MTPC_Australian%20Medicinal%20Cannabis%20Industry.pdf"}],"updated-by":[{"DOI":"10.1186\/s12913-023-09084-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000}}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-09021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-022-09021-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-09021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:03:32Z","timestamp":1674468212000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-022-09021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9021"],"URL":"https:\/\/doi.org\/10.1186\/s12913-022-09021-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2003049\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-2003049\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12913-023-09084-5","URL":"https:\/\/doi.org\/10.1186\/s12913-023-09084-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Massey University Human Ethics Committee reviewed the study protocol and provided ethics approval (SOA 18\/85). The study was performed in accordance with ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent was gained from all participants before the interview.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}